Overview
Naohiko Koide practices practicing medicine in Kiso, Japan.
Their clinical expertise encompasses Stomach Cancer, Esophageal Cancer, Gastrectomy, and Endoscopy.
They are actively involved in clinical research, co-authoring 21 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Naohiko Koide
Is Naohiko Koide a top-rated expert for Gastrectomy?
MediFind is an objective health platform that identifies experts based on real-world data. Naohiko Koide is classified as an Experienced expert for Gastrectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Naohiko Koide participate in research or clinical trials?
Yes. Naohiko Koide has published 21 articles and abstracts on conditions like Gastrectomy. You can view a list of Naohiko Koide's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ColonoscopyKoide isExperienced. Learn about Colonoscopy.
- EndoscopyKoide isExperienced. Learn about Endoscopy.
- Esophageal CancerKoide isExperienced. Learn about Esophageal Cancer.
- GastrectomyKoide isExperienced. Learn about Gastrectomy.
- Stomach CancerKoide isExperienced. Learn about Stomach Cancer.